EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

WWP1 inhibition suppresses the proliferation of pancreatic cancer cells by regulating the PI3K-AKT pathway

Genso Notoya, Takahiro Kishikawa iD, Kengo Yasugi, Takuma Iwata, Takahiro Seimiya, Koji Miyabayashi, Ryota Takahashi, Keisuke Yamamoto, Hideaki Ijichi, Motoyuki Otsuka, Mitsuhiro Fujishiro

Journal of Gastroenterology · 2025

DOI: 10.1007/s00535-024-02192-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology, 2025. Verfasst von Genso Notoya und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endoscopy and Endoscopic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Japan Agency for Medical Research and Development, Mochida Memorial Foundation for Medical and Pharmaceutical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The proto-oncogene WWP1 is overexpressed in various cancers and contributes to tumor growth and poor prognosis. Recently, WWP1 inhibition was reported to suppress tumor development and cell proliferation by activating the PTEN function. However, the expression profiles and clinical significance of WWP1 in pancreatic ductal adenocarcinoma (PDAC) tissues remain undetermined. Therefore, this study aimed to evaluate the WWP1 expression in PDAC and investigate the therapeutic potential of WWP1 inhibition.

Methods

Cellular proliferation assays were performed using a doxycycline-inducible shWWP1 expression system. Transcriptome analyses were conducted to identify the altered pathways in WWP1 -depleted cells. PTEN ubiquitination by WWP1 was confirmed using immunoprecipitation assays. In vivo xenograft and drug screening assays were performed to evaluate the clinical significance of WWP1 inhibition.

Results

WWP1 was significantly upregulated in PDAC tissues and associated with poor prognosis. WWP1 depletion significantly reduced the proliferation of PDAC cell lines, correlating with the suppression of the PI3K-AKT pathway. Mechanistically, as reported in other cancer types, PTEN is a target of WWP1 in PDAC cells. PTEN silencing abrogated the growth-inhibitory effects in WWP1 -depleted cells, suggesting that the anti-tumor effects of WWP1 inhibition are mediated through PTEN activation. In vivo xenograft studies confirmed that WWP1 depletion substantially inhibited tumor growth. Moreover, drug screening assays revealed that WWP1 depletion had an additive effect with the PI3K-AKT pathway inhibitors on hindering tumor growth.

Conclusion

WWP1 inhibition enhances the anti-tumor effects of PI3K-AKT pathway inhibitors through PTEN activation. Thus, WWP1 could be a potential therapeutic target in PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Protein LigasesPancreatic NeoplasmsCarcinoma, Pancreatic DuctalProto-Oncogene Proteins c-aktHumansCell ProliferationPTEN PhosphohydrolaseAnimalsCell Line, TumorPhosphatidylinositol 3-KinasesSignal TransductionMiceProto-Oncogene MasMice, NudeUp-RegulationMaleXenograft Model Antitumor AssaysFemaleGene Expression Regulation, NeoplasticPrognosis

Stichwörter der Autor:innen

PI3K inhibitorPTENPancreatic cancerWWP1

Substanzen

Ubiquitin-Protein LigasesPTEN PhosphohydrolaseProto-Oncogene Proteins c-aktPTEN protein, humanWWP1 protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene MasMAS1 protein, human

Autor:innen und Institutionen

  • Department of Endoscopy and Endoscopic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan.
  • Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. tkishikawa-tky@g.ecc.u-tokyo.ac.jp.
  • Clinical Nutrition Center, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan.

ORCID-Profile: Takahiro Kishikawa

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology
  • Japan Agency for Medical Research and Development
  • Mochida Memorial Foundation for Medical and Pharmaceutical Research
  • Kobayashi Foundation for Cancer Research
  • The University of Tokyo

Zitieren

APA

Notoya, G., Kishikawa, T., Yasugi, K., Iwata, T., Seimiya, T., Miyabayashi, K., Takahashi, R., Yamamoto, K., Ijichi, H., Otsuka, M., & Fujishiro, M. (2025). WWP1 inhibition suppresses the proliferation of pancreatic cancer cells by regulating the PI3K-AKT pathway. Journal of Gastroenterology. https://doi.org/10.1007/s00535-024-02192-x

Vancouver

Notoya G, Kishikawa T, Yasugi K, Iwata T, Seimiya T, Miyabayashi K, et al. WWP1 inhibition suppresses the proliferation of pancreatic cancer cells by regulating the PI3K-AKT pathway. Journal of Gastroenterology. 2025. doi:10.1007/s00535-024-02192-x

BibTeX
@article{Notoya2025,
  author = {Notoya, Genso and Kishikawa, Takahiro and Yasugi, Kengo and Iwata, Takuma and Seimiya, Takahiro and Miyabayashi, Koji and Takahashi, Ryota and Yamamoto, Keisuke and Ijichi, Hideaki and Otsuka, Motoyuki and Fujishiro, Mitsuhiro},
  title = {WWP1 inhibition suppresses the proliferation of pancreatic cancer cells by regulating the PI3K-AKT pathway},
  journal = {Journal of Gastroenterology},
  year = {2025},
  doi = {10.1007/s00535-024-02192-x}
}
Kostenlos starten →